A prospective, randomised trial has shown that standard adjuvant chemotherapy is superior to capecitabine in the treatment of women with breast cancer aged 65 years or older; on the basis of the results of this [more]
Imaging is performed in patients with early-stage non-small-cell lung cancer (NSCLC) for disease staging and to identify the patients most likely to benefit from surgery. Two recent randomised trials compared conventional staging plus PET with [more]
Selected reports edited by Janet Fricker Download full article
Deciding to start a family is the most momentous decision many people will ever take. For someone living with a cancer diagnosis, new life can seem particularly important, but it also carries particular risks. Download [more]
Keeping your life together when you have cancer is hard. To achieve this and still find the energy to work with other patients to influence decisions that shape the services and treatments you rely on [more]
Early aggressive treatment in patients whose cancer is likely to progress slowly, if at all, causes side-effects and reduces their quality of life for no benefit. Can active surveillance avoid this? Download full article
Advances in cancer surgery over the past couple of decades have led to significant increases in cure rates in many cancers. How can we ensure these new techniques don’t put at risk the gains of [more]
Rabiya Tuma won a Best Cancer Reporter Award for her contributions to The Economist. Here her article highlights some of the growing evidence about the role of stem cells in cancer. Download full article
In five brief years on the political stage in Brussels, Adamos Adamou successfully built alliances, mongered resolutions and agitated for action aimed at ensuring all of Europe’s citizens have access to quality screening and treatment. [more]
How do you help close the gap between the worst and the best cancer outcomes in Europe, when you have no legal basis for intervening in Member States’ health policies and have precious little money [more]